PMV PHARMACEUTICALS, INC.

Analyst Reco. PMV Pharmaceuticals, Inc.

Equities

PMVP

US69353Y1038

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
1.75 ^USD	+2.34%		+8.70%	-43.55%

04-12	Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target	MT
03-27	PMV Pharmaceuticals, Inc. Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220c-Positive Solid Tumors	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target	04-12	MT
Ladenburg Thalmann Initiates PMV Pharmaceuticals at Buy With $7 Price Target	12-27	MT
HC Wainwright Cuts Price Target on PMV Pharmaceuticals to $5 From $29, Maintains Buy Rating	16/10/23	MT
HC Wainwright Adjusts PMV Pharmaceuticals Price Target to $29 From $35, Maintains Buy Rating	11/08/23	MT
HC Wainwright Adjusts Price Target on PMV Pharmaceuticals to $35 From $36, Keeps Buy Rating	20/03/23	MT
Oppenheimer Adjusts PMV Pharmaceuticals' Price Target to $15 From $28, Maintains Outperform Rating	02/03/23	MT
HC Wainwright Adjusts PMV Pharmaceuticals' Price Target to $36 From $63, Keeps Buy Rating	17/11/22	MT
Oppenheimer Adjusts PMV Pharmaceuticals Price Target to $28 From $33, Maintains Outperform Rating	10/08/22	MT
Oppenheimer Adjusts PMV Pharmaceuticals Price Target to $33 From $30, Maintains Outperform Rating	09/06/22	MT
Goldman Reduces PMV Pharmaceuticals' Price Target to $25 From $43, Buy Rating Kept	24/05/22	MT
Oppenheimer Upgrades PMV Pharmaceuticals to Outperform From Perform, Sets $30 Price Target	02/03/22	MT
PMV PHARMACEUTICALS : Goldman Sachs Upgrades PMV Pharmaceuticals to Buy From Neutral, Lifts Price Target to $43 From $35	22/09/21	MT
PMV PHARMACEUTICALS : Oppenheimer Initiates Coverage on PMV Pharmaceuticals With Perform Rating	19/08/21	MT
PMV PHARMACEUTICALS : Guggenheim Starts PMV Pharmaceuticals at Buy With $56 Price Target	02/08/21	MT
PMV PHARMACEUTICALS : HC Wainwright Starts PMV Pharmaceuticals at Buy With $63 Price Target	29/07/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer